Rahul Anil Sheth

39PUBLICATIONS
221CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Mar 14, 2026
AI-Assisted OCT Imaging for Core Needle Biopsy Guidance: The 1st in Humans Study.

Nicusor Iftimia, Poonam Yadav, Michael Primrose

|Jan 02, 2026
Association between Three-dimensional Margin Assessment and Local Tumor Control in Percutaneous Lung Cryoablation of Colorectal Metastases.

Frank Mohn, Koustav Pal, Caleb O'Connor

|Dec 10, 2025
Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors.

Mohamed E Abdelsalam, Kamran Ahrar, Rahul A Sheth

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

Pageof 7

Frequent Collaborators

6 joint publications

Koustav Pal

6 joint publications

Bruno C Odisio

6 joint publications

Pavlos Msaouel

5 joint publications

Jianjun Gao